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The objective of this research was to study the possible synergistic 
action of the antioxidant Butylated hydroxytoluene (BHT) with Dimethyl 
Sulfoxide (DMSO) and 2,2,6,6-tetramethyl-4-oxo-piperidin-1-oxyl (TEMPONE) 
on Chinese hamster ovary (CHO) cells. 
CHO cells were treated with 1.0, 5.0 and 10 ug/ml BHT and 1% DMSO 
for 48 hrs. Similar procedures were also used for the interaction of BHT 
and TEMPONE. Moderately high frequencies of chromosomal aberrations (18%) 
and aberrant cells (17%) were observed when cell cultures were exposed to 
1.0 ug/ml BHT for 48 hr; these aberrations included breaks, gaps, rings, 
polyploids and endoreduplications. When cultures were exposed to 10 ug/ml 
BHT, there was a significant decrease in chromosomal aberrations. Cyto¬ 
genetic analysis indicated that 1% DMSO significantly increased the per¬ 
centage of chromosomal aberrations and aberrant cells in CHO cell cultures 
treated for 48 hr. CHO cells treated with 1.0 ug/ml BHT and 1% DMSO 
simultaneously showed a significant decrease in chromosomal aberrations. 
In contrast, cells exposed to 10 ug/ml BHT and 1% DMSO had a significant 
increase in chromosomal aberrations. 
In other studies, (CHO) cells were exposed to 1.0, 5.0 and 10 ug/ml 
TEMPONE. Cytogenetic analysis also revealed that TEMPONE caused chromo¬ 
somal aberrations (23%) and aberrant cells (17) in CHO cell cultures. 
There was no significant difference in chromosomal aberrations or aber¬ 
rant cells when CHO cell cultures were treated with 1.0, 5.0 or 10 ug/ml 
BHT and 1.0, 5.0 or 10 ug/ml TEMPONE. The results obtained suggest that 
interactions between the test compounds may be toxic to the cells and 
thus could be responsible for the observed reduction in chromosomal 
aberrations and aberrant cells percentages. 
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Over the years numerous hypotheses have been suggested to explain the 
phenomenon of aging and cancer. The most widely accepted hypothesis is 
the somatic mutation theory (Scribner and Suss, 1978). The theory post¬ 
ulates that chromosomal damage, spontaneously or by various agents, may 
lead to the synthesis of the wrong protein or the failure to produce an 
important one (Curtiss, 1966). The damage or mutation will be perpetu¬ 
ated to all daughter nuclei following cell division, which over a period 
of time could lead to signs of aging or cancer. Many of the agents (e.g. 
ionizing radiation, cigarette smoke, chimney smoke and vehicular exhausts) 
which are associated with aging or cancer, exert their effects through 
radical-mediated reactions (Pryor, 1982). 
Butylated hydroxytoluene (BHT), and antioxidant which is commonly 
used in various food products, has been evaluated by investigators to 
determine its biological activity and antioxidant properties. Its 
potential hazardous effects are of major concern to scientists due to 
its extensive usage in fatty foods which are consumed by man. 
Dimethyl sulfoxide (DMSO) an odorless and colorless organic liquid 
is obtained as a by-product of wood pulp (Brown, 1982). DMSO is used 
as a pain reliever, an anti-bacterial agent, a diuretic, and a carrier 
of other drugs. It is also used extensively in agricultural applications 
and veterinary medicine. Due to the extensive use of DMSO as a medicinal 
agent, it was tested to determine its potential mutagenic effects on mam¬ 
malian cells in vitro. 
1 
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TEMPONE (2,2,6,6-tetramethyl-4-oxo-piperidin-1-oxyl) is a stable 
free radical which is used as a probe of membrane structure with elec¬ 
tron spin resonane (ESR). There is evidence that it is produced in the 
atmosphere by photochemical reaction and may react with other chemicals. 
As previously mentioned, agents such as TEMPONE, exert their effects 
through radical mediated reactions; therefore, studies were conducted 
to test its mutagenic effects on mammalian cells in culture. 
The objective of this research was to develop an j_n vitro system 
to study the interaction of Butylated hydroxytoluene (BHT) with Dimethyl 
sulfoxide (DMSO) and 2,2,6,6-tetramethyl-4-oxo-piperidin-l-oxyl (TEMPONE). 
BHT and DMSO, in combination, has been shown to be highly toxic to CHO 
cells i_n vitro (Miller, Personal Communication). These investigations 
sought to determine the possible synergistic action of BHT with DMSO or 
TEMPONE, as revealed by cytogenetic methodologies. TEMPONE (Dawkins et 
al., 1980), and DMSO have been shown to increase chromosomal abnormali¬ 
ties in mammalian cells (Kapp and Eventoff, 1980; Patterson and Smalls, 
1981). Evaluation of the interaction of the test compounds by cytogenetic 
analysis may provide further evidence of the potential role these sub¬ 
stances play in mutagenesis and carcinogenesis. 
CHAPTER II 
REVIEW OF LITERATURE 
Characteristics of Butylated Hydroxytoluene 
The organic compound, Butylated hydroxytoluene (BHT) belongs to a 
group of compounds known as "hindered phenols," in which the phenolic 
group is decreased by the ortho or para substituents in their aromatic 
ring (Lundberg, 1962). 2,6-di-tert-butyl-p-cresol has a molecular 
weight 220.34 g and consists of 81.76% carbon, 10.98% hydrogen and 7.26% 
oxygen. It is commercially known as butylated hydroxytoluene (BHT), 
but is also known by several trade names (e.g. DBPC, Antranane 8, Tenox 
BHT, Ionol CP, Sustane, Dulpac, Impruvol and Vianol). The compound, BHT 
is prepared from p-cresol and isobutylene, and readily inactivates lipid 
containing mammalian and bacterial viruses (Merck Index, 1976). BHT 
is insoluble in water and freely soluble in toluene. It is also soluble 
in acetone, benzene, ethanol, and most hydrocarbon solvents. 
BHT was synthesized initially for use with petrol, petroleum pro¬ 
ducts and rubber (Dacre, 1961). However, in 1954, Dugan, et al. found 
BHT to be an effective antioxidant for animal fats at a concentration of 
0.01%, and legislative measures were taken to approve its addition to 
fats intended for human consumption (Dacre, 1961). Presently, the maxi¬ 
mum concentration of BHT allowable in food products has been set at 
0.02% of the fat and oil content of the food product by the World Health 
Organization (Leslie et jîl_., 1978). The human consumption of this anti- 
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oxidant is estimated to be 2-3 mg/day (Marino and Mitchell, 1972). 
BHT like other antioxidants, is added primarily to prevent rancidity 
of fatty foods and, in some cases, it prevents discoloration (Kermode, 
1972). Some of the products which contain antioxidants such as BHT are 
biscuits, chips, cereals, cooking oils, margarine, salted nuts, soup 
mixes and precooked meals containing fish poultry or meat. 
Butylated hydroxytoluene along with butylated hydroxyanisole (BHA), 
dodecyl gallates, octyl, propyl and natural or synthetic tocopherols 
singly or in combination are commonly used antioxidants (Kermode, 1972). 
The antioxidant effect of these compounds may be enhanced when combined 
with ascorbic, citric or phosphoric acid (Kermode, 1972). Also, when 
two or more antioxidants are used in food products, a synergistic effect 
may evolve. 
The Metabolism of Butylated Hydroxytoluene 
Dacre (1961) studied the metabolism of BHT by administering BHT dis¬ 
solved in olive oil via stomach tubes to New Zealand white rabbits. 
Dacre showed that 3,5-di-tert-butyl-4-hydroxybenzoic acid is a metabolite 
of BHT. He also noticed that the complete excretion of BHT metabolites 
takes place 3-4 days after its administration to the animals. Fifty-four 
percent of the administered dose was recovered from the rabbit mainly as 
glucuronides, approximately 16% as an ether glucuronide. 
Daniel et aj_. (1967) randomly labelled BHT and BHA to test the 
rate and route of elimination of these antioxidants in man. Each 
antioxidant was labelled with [^C] and weighed into a gelatin capsule 
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with sufficient unlabelled material to bring the total dose to 40 mg. 
They reported that 75% of the administered labelled BHT is excreted in 
the urine. In contrast, 80-90% of the C^C] BHA is excreted in the 
urine by man. The bull: of the radioactivity appeared on the first or 
second day after dosing for both BHA and BHT. The investigators also 
suggested an enterohepatic circulation for the metabolites of BHT since 
a slight excretion continued for a considerable period of time. Ladomery 
et_ aj_. (1967a) reported that BHT is excreted slowly in urine and feces 
because of a rapid enterohepatic circulation in rats, thus confirming 
Daniel et al1s. observations. 
The biliary metabolites of rats given small amounts (100 ug) of 
[l^c] BHT intravenously and intraperitoneally were shown to be 3,5-di- 
t-butyl-4-hydroxybenzaldehyde, 3,5-di-t-butyl-4-hydroxybenzyl alcohol, 
3,5-di-t-butyl-4-hydroxybenzoic acid and 1,2-bis-(3,5-di-t-butyl-4- 
hydroxyphenyl ) ethane (Ladomery et aj_., 1967b). From the four compounds 
mentioned above, 3,5-di-t-butyl-4-hydroxybenzoic acid has been shown to 
be the metabolite that undergoes enterohepatic recirculation (Holder et^ 
al_., 1970). 
Daniel et £]_. (1968) studied the metabolism of BHT in rat and man 
with the aid of [^C] label. It was observed that 3,5-di-t-butyl-4- 
hydroxybenzoic acid is the major metabolite in rat urine, which is in 
accord with Dacre's observations in the rabbit. Other metabolites of 
BHT in the rat urine included mercapturic acid, and S-(3,5-di-t-butyl-4- 
hydroxybenzyl )-N-acetylcysteine. The metabolites found in rat bile con¬ 
sisted almost entirely of the conjugates occurring in urine, the bulk of 
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the radioactivity being due to the glucuronide of 3,5-di-t-butyl-4- 
hydroxybenzoic acid. However, only a minute quantity of mercapturic 
acid and neutral metabolites were present in rat bile. 
The metabolism of BHT in man is different from that which occurs 
in the rat. The amount of 3,5-di-t-butyl-4-hydroxybenzoic acid and its 
glucuronide in the urine is very small, and only a trace of the mer¬ 
capturic acid derivative is present. The major metabolite is an ether 
insoluble glucuronide, 4-carboxy-2-(1 -carboxy-1-methylethyl )-6-(l-formyl - 
1-methylethyl ) phenol (Daniel et £]_., 1968). 
Investigations by Nakagawa et al_. (1980) indicated that BHT is 
converted to chemically activated material(s) by a cytochrome P-450- 
1 inked mono-oxygenase system; it is activated by a cytochrome P-450 with a 
high BHT oxidase activity. Some of the activated material(s) bind to 
cellular macromolecules (e.g. RNA). 
In an effort to determine the biological fate of BHT, Nakagawa et al. 
(1981a) fed male Wistar rats C^C] BHT solution (5 mg/rat, 11 uCi ) dis¬ 
solved in olive oil through a stomach tube. Their results indicated 
that at 6 hours after the administration of [^C] BHT, the amount of 
radioactivity bound to proteins reached its maximum (i.e. 28-30 nmol/g 
tissue). However, in a separate experiment conducted for 7 days, the 
radioactivity incorporated into the nucleic acid fraction increased 
with time, and the level remained constant for one week. The amount of 
[l^C] BHT bound to RNA was about eighteen or thirty-five times that 
in DNA or protein. Furthermore, the amount of radioactive metabolite 
bound to liver macromolecules increased significantly above the untreated 
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control (i.e. RNA 170%, DNA 153% and protein 154%) when animals were 
pretreated with phenobarbitol. 
Nakagawa et a4_. (1981a) using [^C] BHT and rat liver microsomes, 
illustrated that BHT reacts with thiol compounds such as cysteine or 
glutathione, and the binding sites of protein for such material(s) may be 
the sulfhydryl group. Moreover, it was shown that the binding site of the 
labelled material on liver RNA in the rat was into the molecular structures 
of AMP and GMP rather than being bound to a moiety of the nucleotides 
(Nakagawa et^ al_., 1981b). 
The Effects of Butylated Hydroxytoluene on Cells In Vitro and Mammals 
Butylated hydroxytoluene has been reported to affect various organs, 
enzymes and cell types. For example, BHT has been reported to increase 
(1) lung weight (Sahab and Witschi, 1975; Witschi et_ aj_., 1976; Omaye 
et^ aj_., 1977; and Mizutani et_ cU_., 1982), (2) lung damage (Marino and 
Mitchell, 1972), (3) proliferation of alveolar cells (Mizutani et al., 
1982), (4) pulmonary DNA (Marino and Mitchell, 1972; Sahab and Witschi, 
1975; Witschi et_ aj_., 1976; Omaye et al_., 1977; and Witschi and Lock, 
1978), (5) nucleotide activity in the lung; (6) pulmonary glucose-6- 
phosphate dehydrogenase (G6PDH); (7) DNA polymerase, (8) thymidine kinase 
activity (Witschi et al_., 1976); and (9) superoxide dismutase (Omaye et_ 
al., 1977). Omaye et_ £l_. (1977) also detected diffuse subpleural hemor¬ 
rhages when rats were given BHT by intraperitoneal injection. Hémorragie 
effects were also detected by Takahashi and Hiraga (1978a) when they fed 
rats BHT as part of their diet. The investigators observed spontaneous 
massive bleeding into the pleural and peritoneal cavities or external 
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hemorrhage in all expired animals after forty days of treatment. 
Omaye et a]_. (1977) and Takahashi and Hiraga (1978a) postulated 
that the structural characteristic rather than the antioxidant properties 
of BHT appeared to be the cause of hemorrhages and lung changes. This 
postulation was tested by Takahashi and Hiraga (1978b) when they fed male 
Sprague Dawley rats five antioxidants or substituted phenol singly for 
3 weeks. Hemorrhagic properties were not characteristic of all anti¬ 
oxidants therefore, the hemorrhagic effects of BHT appear to be related 
to its chemical structure. 
Clapp et al_. (1973) reported that long term effects of BHT (0.75%) on 
BALB/c mice led to the development of marked hyperplasia of the hepatic 
bile ducts with an associated subacute cholangitis. Branen et_ aj_. (1973) 
showed that the liver and plasma cholesterol level were lowered, and the 
lipid-phosphorus levels in the plasma were increased by BHT. In addition, 
animals receiving BHT while on protein-deficient diets expressed a de¬ 
crease in body weight, and an increase in liver weight (Nikonorow and 
Karlowski, 1973). Decreases in the activity of asparate aminotransferase, 
glucosephosphate isomerase and fructose-diphosphate in liver homogenates 
have also been reported. 
The effects of BHT on monkeys, which are phylogenetically related to 
man, has disclosed some interesting results. For example, monkeys given 
large doses (500 mg/kg/ body weight) of BHT showed only moderate proli¬ 
feration of the smooth endoplasmic reticulum (ER) and increased activity 
of nitroanisole demethylase (Allen and Engblom, 1972); whereas, rats 
given the same dosage of BHT had hypertrophic livers and showed marked 
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proliferation of the smooth ER, a decrease in glucose-6-phosphate and an 
increase in a number of drug metabolizing enzymes. 
BHT has been shown to reduce chromosomal breaks in blood leuko¬ 
cyte cultures treated with sodium cyclamate and 7,12-dimethylbenz(alpha) 
anthracine (Shamberger, et aj_., 1973). It affects the metabolism of 
N-2-f 1 uorenylacetamide and N-hydroxy-N-2-fluorenylacetamide (Grantham, 
et a_l_., 1973) and protects against 1,2 dimethyl-hydrazine carcinogenesis 
in BABL/c mice (Clapp et £]_., 1979). BHT also provide protection to rats 
against hepatocarcinogenesis produced by 0.05% 31-methyl-Adimethyamino¬ 
benzene (Daoug and Griffin, 1980). Furthermore, BHT has been reported 
to be a promoter of adenoma formation in the lungs of Swiss-Webster mice 
initiated with urethan (Witschi and Lock, 1979). 
Chinese hamster embryo cells treated with 0.02 uM/ml BHT and 0.002 
uM/ml Vitamin E were capable of reducing toxicity induced by choles¬ 
terol derived photoproducts (Chan et al_., 1980). Kaul (1979) used cary- 
opsis of barley and growing root meristemic tips of onion to illustrate 
that 4 and 6 mM BHT significantly reduced the germination of seeds 
and produced seedling injury. 
Butylated hydroxytoluene dissolved in dimethyl sulfoxide was examined 
for its cytotoxicity in cultured rat heart cells. A concentration of 
0.45 mM BHT produced leakage of lactic dehydrogenase from cultured myo¬ 
cardial and endotheloid cells into the culture medium, which is indic¬ 
ative of cardi otoxicity (Leslie et_ aj_., 1978). 
Butylated hydroxytoluene has been shown to inhibit a number of 
cellular processes. For example, it has been shown that BHT inhibits 
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RNA and protein synthesis (Milner, 1967) and DNA synthesis (Milner, 
1967 and Witschi and Cote, 1 977). BHT has been reported to inhibit 
the activity of NADPH cytochrome £ reductase, benz(a)pyrene hydroxylase 
and lipid peroxidation (Vainio, 1974). BHT also inhibits the develop¬ 
ment of intestinal tumors in rats concurrently receiving a weekly sub¬ 
cutaneous injection of azoxymethane (Weisburger et_ £l_., 1977). Daugherty 
et_ aj_. (1978) observed that BHT inhibited semiconservative DNA repli¬ 
cation. Also, BHT inhibited the mutagenic effects of benz(a) pyrene in 
Chinese hamster lung V-79 cells cocultivated with x-irradiated hamster 
embryo cells (Katoh et al_., 1980). 
Characteristics of Dimethyl Sulfoxide 
Dimethyl sulfoxide (DMSO) is a highly polar, water-miscible, practi¬ 
cally odorless and colorless organic liquid. It occurs naturally within 
the environment in natural waters and phytoplankton growth medium (Pearson 
et_ al_., 1981). DMSO has also been found naturally in an assortment of 
fruits, vegetables, grains and beverages (i.e., apple, raspberry, alfalfa 
bean, beets, corn, oats, beer, coffee, milk and tea; Pearson, et al. 
1981). Commerically, DMSO is prepared by air oxidation of dimethyl sul¬ 
fide in the presence of nitrogen oxides (Merek Index, 1976). DMSO is 
usually obtained as a by-product of wood pulp manufactured for paper and 
allied industries. In Europe, DMSO is prepared from coal and petroleum 
(Brown, 1982). 
In 1866, a Russian chemist Dr. Alexander Saytzeff, identified DMSO 
but did not bother to further investigate its chemical applications. 
It was not until the 1950's that the study of DMSO was finally revital- 
n 
ized, and the first scientifically documented report of the biological 
significance of DMSO was published (Brown, 1982). The report stated 
that DMSO in a biological system protected cells against freezing damage. 
DMSO also donated protons to other molecules and trapped charged atomic 
particles (Brown, 1982). 
Robert Herschler and Dr. Stanley W. Jacob are authorities on the 
various applications of DMSO (Tarshis, 1981). Herschler, a chemist for 
Crown Zellerbach, became interested in DMSO when he discovered that it 
possessed the ability to enhance plant growth, to transfer fungicidal 
and antibiotic agents, and to speed up the absorption of these agents 
in plants. Thus, Herschler became aware of the potential medicinal 
applications of DMSO and introduced the chemical to Dr. Jacob. Col¬ 
laborative studies were undertaken between scientists at the University 
of Oregon Medical School and Crown-Zellerback Co. The results indicated 
that DMSO could penetrate the skin and cellular membranes when applied 
topically, and could carry other substances along with it. The earlier 
studies conducted by Herschler and Jacob convinced them that DMSO relieved 
pain, reduced swelling, slowed the growth of bacteria and improved blood 
supply to organs (Tarshis, 1981). 
Metabolism of Dimethyl Sulfoxide 
Dimethyl sulfide, one of DMSO's main metabolites, can be produced 
in virtually all marine plant life. In tropical climates the sun draws 
dimethyl sulfide from plants into the atmosphere where it reacts in the 
ozone layer to produce DMSO (Tarshis, 1981). Dimethyl sulfide (DMS) 
along with dimethyl sulfone (DMSO2), an odorless compound that is stable 
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within the body, are the major metabolites of DMSO excreted in the urine 
of man (Brown, 1982). It has been reported that dimethyl sulfide is the 
cause of the sulfurous, garlic-onion-oyster breath and body odor of many 
patients who receive DMSO treatment. 
Dimethyl sulfone and dimethyl sulfide are only two of the meta¬ 
bolic products of DMSO. Koulkes-Pujo et_ al_. (1981) reported that 
both hydrogen atoms and hydroxyl radicals react with dimethyl sulfoxide 
in aqueous acid solution to produce methane. The formation of methane 
in a biological system has been used as an indication of the presence 
of 0H“ radicals. But Koulkes-Pujo et ^1_. could not support the yield 
of methane as a direct measure of the presence of OH" radicals. However, 
the investigators did suggest three mechanisms by which OH" radicals 
could be generated: 
(1) Fenton reaction: Fe^++H202 Fe^++ OH + OH" 
(2) Harber-Weiss reaction: O2” + H2O2 OH + OH" + O2 
(3) In biological processes such as microsomal electron transfer re¬ 
actions. 
In contrast, Klein et ^1_., (1981) used three different oxygen radical 
producing systems to substantiate the ability of DMSO to be oxidized to 
formaldehyde in biological systems: (a) xanthine-xanthine oxidase model, 
(b) ascorbic acidiron-EDTA model and (c) NADPH-dependent electron trans¬ 
fer by rat liver microsomes . In all three reaction systems the oxi¬ 
dation of DMSO was found to yield formaldehyde rather than methane as a 
predominant product. Hyland and Auclair (1981) reported that the re¬ 
action between OH", O2 and DMSO involves the transfer of one electron 
to molecular oxygen with the formation of 0*2". The reaction below 
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illustrates how such a reaction could occur. In this particular re¬ 
action, a proton is extracted from the activated methyl group of DMSO, 
thus leading to the formation of the methyl sulphinyl carbanion: 
H-HoC v 




s - 0 + H20 
In DMSO, OH* is removed by the following sequence of reactions: 
(1) OH- + (CH3)2 SO - » CH3SOOH + CH3* 
(2) CH3- + 02 » CH302- 
(3) CH3O2- + CH3O2- —► CH3 OOCH3 + o2. 
The Properties of Dimethyl Sulfoxide 
One of the properties of DMSO is its ability to penetrate biological 
membrane without permanently altering or damaging the membrane structure. 
Two theories have been proposed to account for this phenomenon. Firstly, 
DMSO may replace the water molecules which are "bound" to the proteins 
and interact with these proteins to temporarily alter the geometric 
shape of the protein molecule (Tarshis, 1981). Secondly, DMSO may promote 
an osmotic effect by building up a pressure on the exterior of the mem¬ 
brane, thus changing the chemical conformation of the membrane in a 
manner which allows DMSO to move freely in and out. 
In summary, the applications of DMSO are highly diversified; for 
example it may be used as a pain reliever for such acute injuries as 
sprains, burns and cuts. It may also be used as an anti-bacterial agent, 
an anti-inflammatory agent, a collagen-softening agent, a diuretic, a 
cholinesterase inhibitor, a vasodilator, a carrier of other drugs, a 
reducer or enhancer of drugs, a controlling mechanism with autoimmune 
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disease, a muscle relaxant or a cell protectant (Tarshis, 1981). 
The Effects of Dimethyl Sulfoxide on Cells In Vitro and Animals 
Dimethyl sulfoxide has been reported to have various deleteri¬ 
ous as well as beneficial effects on cells and animals. For example, 
Yee et aj_. (1972) showed that treatment of Saccharomyces cerevisiae 
yeast strains with increasing concentrations of DMSO resulted in de¬ 
creasing cell viability. They also reported that 40% DMSO resulted 
in non viable, intact cells which retained enzymatic activities. Haigler 
and Spring (1981) compared the analgesic effects of DMSO and morphine 
in rats. It was reported that the two chemicals were comparable in the 
ability to relieve pain, however, DMSO relieved pain for a longer period 
of time. 
The cytogenetic effects of DMSO have also been reported in recent 
years. For example, Patterson and Smalls (1981) reported that up to 27% 
chromosomal aberrations occurred in Chinese hamster ovary cell cultures 
exposed to solutions of 1 to 4% DMSO as compared to untreated cell cul¬ 
tures. Kapp and Eventoff (1980) reported that DMSO caused chromosome 
damage in rat bone marrow cells even at low levels (1%). They also 
observed a direct correlation between the increase in cytogenetic aber¬ 
rations and the increase in the concentration of DMSO. Sass (1981) re¬ 
ported that Chironomus tentans larvae treated with 10% DMSO demonstrated 
an activation and repression of specific gene transcription. This was 
found primarily in the Balbiani rings (BR) a characteristic reaction 
pattern involving BRI, BR2 and BR3, all in salivary gland chromosome IV. 
Reports of the beneficial effects of DMSO on cells and animals have 
been documented also. Mollet (1976) observed that 1% DMSO did not induce 
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any genetic alterations in Drosophila larvae and was also non-toxic. 
Repine et aj_. (1981) reported that 80% of the single-stranded DNA 
breaks induced by irradiation were prevented by DMSO. 
Therapeutic Uses of Dimethyl Sulfoxide 
The various beneficial properties of DMSO are numerous in thera¬ 
peutic medicine, veterinary medicine and agricultural applications. DMSO 
is used therapeutically in humans for the following disorders: sclero¬ 
derma, bursitis, arthritis, cancer, back pain, chronic pain, "frozen 
shoulder", interstitial cystitis (which, as of the spring of 1981, was 
the only condition for which a DMSO medication was approved by the FDA), 
dental pain, ear disease, eye disease, gastro-intestinal diseases, head¬ 
aches, gout, hemorrohoids, herpes virus infections, phlebitis, pruritus 
ani, Raynaud's Disease, shingles, sinusitis and tendinitis (Tarshis, 
1981 ). 
Svingen et jal_. (1981) reported that alpha-tocopherol and DMSO 
provided protection against adriamycin skin ulcers in the rat. It was 
surmised that DMSO probably increased the penetration of alpha-toco¬ 
pherol succinate into the skin. The effects of DMSO on renal function 
in man has been investigated; Muther and Bennett (1980) showed that 
DMSO has little or no nephrotoxic reactions on human patients (male 
and female). It was reported that patients treated with DMSO for 
severe cerebral edema can continue to serve as a source of donor organs 
for renal transplantation. DMSO has been shown to provide protection 
from ischemic damage in experimentally induced cerebral edema (De la 
Torre and Surgeon, 1976) DMSO has also been reported to offer protection 
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against the development of uremia following renal artery clamping. 
DMSO is also used in veterinary medicine and the agricultural in¬ 
dustry. The 90% gel form of DMSO has been approved since 1970 for con¬ 
tusion, sprains, cuts, excess scar tissue, post-operative infestions, 
myositis, rattle snake bite and torn toenail for animals (Tarshis, 1981). 
Within the agricultural industry, DMSO has various uses: it enhances the 
ability of plant roots to absorb nutrients, water and pesticides; it 
gives both plants and vegetables grown in a green house much the same 
color as that of field-grown plants and vegetables; it stimulates plant, 
flower and vegetable growth; it protects plants and vegetables from 
freezing; and it helps prevent disease in many plants, trees and vege¬ 
tables (Tarshis, 1981). 
Biologically Significant Free Radicals 
The spin label 2,2,6,6-tetramethyl-4-oxo-piperidin-l-oxyl (Tempone) 
is a stable nitroxide free radical which is used in electron spin reson¬ 
ance (ESR) as a probe for membrane structure. Tempone represents only one 
of the common free radicals species or precursors derived from photo¬ 
chemical air pollution. Other free radical species encountered by cells 
are 02*", H202, OH and A g02 via oxygen metabolism; N02, O3 and peroxy- 
acylnitrates through photochemical air pollution; lipid peroxides via 
by-products of free radical propagation or prostanoid metabolism; hypo- 
chloride formation by inflammation; semiquinones via mitochondrial elec¬ 
tron transport; aromatic hydrocarbons (environmental); and divalent met¬ 
als containing proteins (Freeman and Crapo, 1982). 
Pryor (1982) catagorized the four major types of radical generating 
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xenobiotics: (1) toxins which are themselves free radicals or contain 
free radicals (e.g. N0-|,NO2, soot, tar and tobacco smoke); (2) non-radi¬ 
cals which cause radicals to be formed in molecules such as ozone or 
singlet oxygen; (3) toxins which interrupt cellular electron flow and 
form radicals by single-electron transfer reactions such as CCI4, nitro- 
furan drugs, paraquat and bloomycin; and, (4) toxins that undergo auto¬ 
oxidation to form superoxide and/or hydrogen peroxide. 
Most radicals are extremely reactive and usually exist only at very 
low concentration (e.g. 10~5 to 10_9M). Radical reactions are generally 
formed in three steps-initiation, propagation and termination. Radicals 
are generated in the initiation step, they are conserved in the propa¬ 
gation step and in the termination step, some of the radicals may be 
eliminated. 
There are four mechanisms by which radical chain reactions might be 
initiated in vivo: (1) molecule-induced homolysis, in which radicals are 
produced at rates which are faster than expected due to an interaction 
between different types of molecules; (2) redox-reactions, (3) photolysis 
and (4) radiolysis (Pryor 1973 and 1976). In addition to the four above 
mechanisms of initiation, exposure to pollutants (such as ozone, NO2) 
singlet oxygen and enzymatic processes may also produce radicals in 
vi vo. 
Nitrogen oxides are commonly found in polluted air (NO2 and NO) in 
high concentrations (up to 1000 ppm) and in cigarette smoke. Pryor 
(1982) showed that nitrogen dioxide reacted with polyunsaturated fatty 
acids in lung lipids in vivo and with polyunsaturated fatty acids in 
vitro to initiate the autoxidation of the unsaturated fatty acids. In 
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1972, Gray et aj_. reported that NO and NO2 reacted with hydrogen peroxide 
in the gas phase to produce hydroxyl radicals which are extremely damag¬ 
ing in biological systems (Pryor, 1982). 
Dawkins et aJL (1980) reported that there was a significant increase 
above the control levels in sister chromatid exchange frequencies and 
chromosomal aberrations in cells treated with Tempone in vitro. These 
effects, however, were reduced by alpha tocopherol. Freeman and Crapo 
(1982) reported that various anthracyclic antineoplastic agents (e.g. 
adriamycin and daunorubicin) that depend on guinoid groups or bound 
metals for activity are able to generate oxygen radicals which can 
cause tissue damage. Primary radicals may be generated by irradiation 
of organisms with electromagnetic radiation (x-rays and gamma rays) 
and radiation particles (electrons, protons, neutrons, deuterons, and 
alpha and beta particles) via the transfer of their energy to cellular 
components (e.g. water). In addition, a wide variety of environmental 
agents including photochemical air pollutants, hyperoxia, pesticides, 
tobacco smoke, solvents, anesthetics and the general classes of aromatic 
hydrocarbons also cause free radical damage to cells. 
Superoxide radicals (02*") are also very common and may be produced 
within all respiring organisms (Fridovich, 1975). This radical may be 
generated photochemically by photoreduction of flavin mononucleotide, by 
UV radiation, and enzymatically with the xanthine-oxidase system (Emerit 
et al., 1982). This radical may also be generated by cytotoxic agents, 
such as, 6-hydroxy-dopamine, 6-aminodopamine, 6,7-dihydroxytryptamine and 
dialuric acid (Cohen and Heikkila, 1974). 
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The correlation between cancer and free radicals has been scru¬ 
tinized by various investigators, and it has been shown that radicals 
are involved in various types of chemical carcinogenesis and that 
radical scavenging agents, usually antioxidants (e.g. BHA, BHT and 
Vitamin E) protect cell against the effect of certain carcinogens (Pryor, 
1982). 
CHAPTER III 
MATERIALS AND METHODS 
Materials 
Ovary cells of Cricetulus griseus, the Chinese hamster, were obtain¬ 
ed from American Type Culture Collection, Rockville, Maryland. Corning 
culture flasks (25cm^, 75cm^,and 150cm2) were purchased from VWR Scienti¬ 
fic, Inc., Atlanta, Georgia. Colcemid, Ham's Nutrient Medium F10, Fetal 
Bovine Serum (FBS), Kanamycin solution (10,000 ug/ml kanamycin base), 
Earle's Balance Salt Solution (EBSS-without calcuim, magnesium or phenol 
red), Trypsin (0.25%) were purchased from Grand Island Biological Com¬ 
pany, Grand Island, New York. 2,6-di-tert-butyl-pcresol (Butylated 
hydroxytoluene) was purchased from Calbiochem-Bering Corp. La Jolla, 
California. Dimethyl sulfoxide (DMS0) was obtained from Aldrich Chemical 
Co., Milwawkee, Wisconsin. Ethanol (190 proof) was purchased from Pub- 
licker Industries, Inc., Philadelphia, Pennsylvania. TEMP0NE (2,2,2,6- 
tetramethyl-oxo-piperidin-l-oxyl), was obtained from Eastman Kodak Co., 
Rochester, New York. Giemsa blood stain was purchased from Carolina 
Biological Supply Company, Burlington, North Carolina. A clinical centri¬ 
fuge (model HN-SII) was purchased from VWR Scientific, Inc., Atlanta, 
Georgia. An CO2 incubator (model 330) was purchased from NAPC0 (National 
Appliance Company). 
Methods 
Chinese hamster cells were grown in a monolayer in 75cm^ flasks 
with 15 ml of Ham's medium containing 10% fetal bovine serum and 
100 ug/ml kanamycin. After two days of growth, control and experimental 
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flasks were prepared for study. For synergistic studies, five cell 
culture flasks were prepared for each experiment: Flask 1, untreated 
control; Flask 2, experimental I contained 1.0 ug/ml of BHT; Flask 3, 
experimental II contained 1.0 ug/ml TEMPONE; Flask 4, experimental III 
contained 1.0 ug/ml BHT and 10 ug/ml TEMPONE; and Flask 5, the ethanol 
control, which contained an equal volume of ethanol (BHT solvent) that 
was added to the BHT treated experimental flasks. The cells were grown 
in the presence of these agents for 48 hours. Similar procedures were 
used for the analysis of 1% DMSO and various concentrations of BHT 
(i.e. 1,5 and 10 ug/ml) on CH0 cells. 
Procedures for Chromosomal Analysis 
1. The medium was poured into centrifuge tubes and the cells were 
washed with 10 ml of Earle's Balanced Salt Solution (EBSS) with¬ 
out Ca++, Mg++ or phenol red; the EBSS was also poured into centri¬ 
fuge tubes. 
2. Trypsin (1 ml) was added to the flasks for 1 minute; it was de¬ 
canted and the flasks were incubated for 3-5 minutes. 
3. After detachment of the cells, they were resuspended in 10 ml of 
Ham's nutrient medium without serum, transferred to the centri¬ 
fuge tubes and centrifuged at 1,200 RPM for 6 minutes. 
4. The cells were resuspended in 10 ml of EBSS, centrifuged at 1,200 
RPM and the supernatant was discarded. 
5. The cell pellet was resuspended in 1% sodium citrate, incubated 
at 37°C for 25 minutes, and fixed in a mixture of acetic acid and 
methanol (1:3) for 30 minutes at room temperature. 
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6. The cells were placed on cold wet slides, allowed to air dry, and 
stained with diluted Giesma stain (1:10) for 10 minutes. 
7. The slides were dehydrated in acetone for 15-20 seconds, acetone 
xylene (1:1) for 15-20 seconds and xylene 30-60 seconds; following 
dehydration, the slides were made permanent with Permount mounting 
medium. 
8. For experimental observation and data collection, the slides were 
labelled with an experimental number and code. 
9. In order to reduce subjectivity in data recording, the experimental 
number and code were covered with a slip of paper and taped by an 
assistant prior to the reading of aberrations for each slide. 
10. Each slide was assigned a second slide code number by the assis¬ 
tant which was different from the first code. 
11. The slides were not decoded until chromosome aberrations were 
counted on at least 100 well spread metaphase cells per slide. 
12. All data were statistically analyzed by the student's t-test for 
comparison of individual sample means. 
CHAPTER IV 
EXPERIMENTAL RESULTS 
The data for the interaction of BHT with DMSO or TEMPONE was 
sub-divided into two major groups: (1) chromosomal aberrations (e.g. 
gaps, breaks, rings, etc.); and (2) aberrant cells (i.e. endoredupli- 
cations and polyploids). This format was developed to compare and 
contrast the mutagenic effects of these compounds as indicated by 
chromosomal aberrations with an increase in cell ploidy. 
The data for the cytogenetic analysis of the interaction of BHT 
with DMSO or TEMPONE is presented in a two part table. The letter "A" 
represents chromosomal damage (i.e. breaks, gaps, ring, etc.) and the 
letter "B" represents aberrant cell - increase in ploidy. In each 
table, A and B refer to the same experiment. Also, aneuploid cells 
were not included in the data since CHO cells are usually aneuploids; 
i.e., their chromosome number may vary from one cell to another. 
The Chinese hamster cell consists of twenty-two chromosomes (twen¬ 
ty autosomes and two sex chromosomes, Fig. 1); however, it usually has 
a modal number of twenty chromosomes. 
BHT and DMSO Studies 
Table 1A shows the effects of 1.0 ug/ml BHT and 1% DMSO on CHO 
chromosomes for 48 hr. The untreated control cells did not contain 
chromosomal aberrations. The total percentage of chromosomal aberr¬ 
ations in the ethanol control was 6%. The types of chromosomal aber¬ 
rations observed in the ethanol control were 1% gaps, 2% breaks, 1% 
rings and 2% polycentrics. Total percentage of chromosomal aberrations 
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Figure 1. Normal Chinese hamster chromosome complement. It consists of 









BHT 1% DMSO 
1.0 ug/ml BHT 
+ 
1% DMSO 
No. of Metaphases Examined 100 100 100 100 100 
Chromosomal Aberrations (%) 
Chromosome Gaps 0 0 1.0 2.0 0 
Chromosome Breaks 0 0 0 1.0 1.0 
Chromatid Gaps 0 1.0 1.0 4.0 0 
Chromatid Breaks 0 2.0 4.0 5.0 0 
Chromatid Fusions 0 0 1.0 0 0 
Rings 0 1.0 2.0 1.0 1.0 
T riradial s 0 0 0 1.0 0 
Polycentri es 0 2.0 5.0 0 4.0 
Pulverized Chromosomes 0 0 2.0 2.0 0 





BHT 1% DMS0 
1.0 ug/ml BHT 
+ 
1% DMS0 
Complex Interchanges 0 0 1.0 1.0 2.0 
Quada radiais 0 0 0 2.0 2.0 
Fragments 0 0 1.0 0 0 
Total Chromosomal Aberration (%) 0 6.0 18.0 19.0 10.0 
Mean + SE/Metaphase — • 06+.027 .18+.039 .19+.040 .10+.031 
t-test — aNo significant a»^significant Significant Significant 
difference at increase at increase at increase at 







at-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
^t-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
ct-test: Level of significance for increase/decrease in aberrations compared with mean value for 
1.0 ug/ml BHT. 
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observed in expérimentais treated with 1.0 ug/ml BHT for 48 hr was 18%; 
specific aberrations include 2% gaps, 4% breaks, 1% fusions, 2% rings, 
5% polycentrics, 2% pulverized chromosomes, 1% complex interchanges and 
1% fragments. The total percentage of chromosomal aberrations observed 
in expérimentais treated with 1% DMSO for 48 hr. was 19%. The specific 
aberrations were 6% gaps, 6% breaks, 1% rings, 1% triradials, 2% pulver¬ 
ized chromosomes, 1% complex interchanges and 2% quadraradials. Fig¬ 
ure 2 is a CHO cell treated with 1% DMSO, resulting in a chromatid break 
and gap. In the expérimentais treated with 1.0 ug/ml BHT 1% DMSO for 48 
hr., there was a significant decrease in the total percentage (10%) of 
chromosomal aberrations when compared to 1.0 ug/ml BHT alone. The 
following percentages of chromosomal aberrations were observed: 1% 
breaks, 1% rings, 4% polycentric, 2% complex interchanges and 2% quadra¬ 
radials. 
The effects of 1.0 ug/ml BHT and 1% DMSO on CHO chromosomes for 
48 hr. are shown in Table IB. The total percentage of aberrant cells 
observed in untreated control cells was 6% polyploids. Cells treated 
with ethanol only showed 5% polyploids. Experimental cells treated 
with 1.0 ug/ml BHT + 1% DMSO contained a total of 16% aberrant cells as 
compared to 17% in expérimentais cells treated with 1.0 ug/ml BHT alone. 
There was no significant difference in percent aberrant cells between 
the two expérimentais; however, there was a significant increase in 
aberrant cells in both expérimentais when compared to the ethanol con¬ 
trol. The types of aberrant cells observed in the expérimentais treated 
with 1.0 ug/ml BHT were 3% endoreduplications and 14% polyploids. Fig¬ 
ure 3 shows a polyploidy in a CHO cell treated with 1.0 ug/ml BHT. The 
Figure 2. A chromatid break (arrow) and a gap (arrow) in a CHO cell 
treated with 1% DMSO for 48 hr. 1250 x 
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BHT 1% DMSO 
1.0 ug/ml BHT 
+ 
1% DMSO 
No. of Metaphases Examined 100 100 100 100 100 
Aberrant Cells (%) 
Endoreduplications 0 0 3.0 0 1.0 
Polypi oi ds 6.0 5.0 14.0 12.0 15.0 
Total Aberrant Cells (%) 6.0 5.0 17.0 12.0 16.0 
Mean + SE/Metaphase — .05+.032 .17+.044 .12+.040 .16+.043 
t-test ” “ “ aNo significant 
difference at 
.05 level 
Significant aNo significant 
increase at difference at 




aSignificant cNo significant 
increase at difference at 
.05 l vel .05 level 
at-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
bt-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
ct-test: Level of significance for increase/decrease in aberrations compared with mean value for 
1.0 ug/ml BHT. 
Figure 3. A polyploidy in a CHO cell treated with 1.0 ug/ml BHT 




types of aberrant cells observed in the expérimentais treated with 1.0 
ug/ml BHT and 1% DMSO were 1% endoreduplications and 15% polyploids. 
A polyploidy with a dicentric (Fig. 4) was observed in a CHO cell 
treated with 1.0 ug/ml BHT + 1% DMSO. A histogram comparing the 
total percentages of chromosomal aberrations and aberrant cells for 
CHO cells treated with 1.0 ug/ml BHT and 1% DMSO is shown in Fig. 15-1. 
Table 2A shows the effects of 5.0 ug/ml BHT and 1% DMSO on CHO 
chromosomes for 48 hr. The total percentage of chromosomal aberrations 
observed were 1% for the untreated control and 5% for the ethanol control 
as compared to 12% for the experimental cells treated with 5.0 ug/ml BHT 
for 48 hr. The following chromosomal aberration percentages were obser¬ 
ved: 2% gaps, 1% breaks, 3% rings, 1% triradiais, 4% dicentrics and 1% 
pulverized chromosomes. The total percentage of chromosomal aberrations 
observed in experimental cells treated with 1% DMSO for 48 hr. was 16%, 
the specific aberrations observed were 8% gaps, 1% breaks, 1% rings, 
3% dicentrics, 1% centromere separation, 1% fragments and 1% multi-breaks. 
In experimental cells treated with 5.0 ug/ml BHT + 1% DMSO, there was 
no significant increase in the total percentage (16%) of chromosomal 
aberrations when compared to experimental cells treated with 5.0 ug/ml 
BHT alone. Chromosomal aberration type percentages observed included 6% 
gaps, 7% breaks, 1% rings and 3% dicentrics. A chromatid break (Fig. 5) 
is shown in a CHO cell treated with 5.0 ug/ml BHT + 1% DMSO. 
The effects of 5.0 ug/ml BHT and 1% DMSO on CHO chromosomes for 
48 hr. are shown in Table 2B. The total percentage of aberrant cells 
for the untreated control was 3% polyploids; the total percentage of 
aberrant cells for the ethanol control was also 3% polyploids. Total 
Figure 4. A polyploidy with a dicentric (arrow) in a CHO cell treated with 
1.0 ug/ml BHT + U DMSO for 48 hr. 1250X 
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Figure 15-1. Histogram comparing the total percentages of chromosomal 
aberrations and aberrant cells for CHO cells treated with 
1.0 ug/ml BHT and 1% DMSO for 48 hr. CAC, chromosomal aber¬ 
rations control; ACC, aberrant cells control; CAE, chromo¬ 
somal aberrations ethanol; ACE, aberrant cells ethanol; CAB, 
chromosomal aberrations BHT; ACB, aberrant cells BHT, CAD, 
chromosomal aberrations DMSO; ACD, aberrant cells DMSO; CAF, 
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BHT 1% DMS0 
5.0 ug/ml BHT 
+ 
1% DMS0 
Multi-Breaks 0 0 0 1.0 0 
Total Chromosomal Aberration (%) 1.0 5.0 12.0 16.0 17.0 CO cn 
MEAN + SE/METAPHASE .05+.024 .12+.034 .16+.038 . 17+.039 





















Level of significance for 
Controls. 
Level of significance for 
Ethanol Controls. 
Level of significance for 
5.0 ug/ml BHT. 
increase/decrease in aberrations 
increase/decrease in aberrations 
increase/decrease in aberrations 
compared with mean value for 
compared with mean value for 
compared with mean value for 
Figure 5. A chromatid break (arrow) in a CHO cell treated with 5.0 ug/ml BHT 
+ 1% DMSO for 48 hr. 1250X 
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BHT 1% DMSO 
5.0 ug/ml BHT 
1% DMSO 
No. of Metaphases Examined 100 100 100 100 100 
Aberrant Cell (%) 
Endoreduplications 0 0 1.0 0 0 
Polypi oi ds 3.0 3.0 23.0 12.0 9.0 
Total Aberrant Cells (%) 3.0 3.0 24.0 12.0 9.0 
Mean + SE/Metaphase — .03+000 .24+.046 .12+.036 .09+.033 















at-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
bt-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
ct-test: Level of significance for increase/decrease in aberrations compared with mean value for 
5.0 ug/ml BHT. 
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percentage of aberrant cells observed in experimental cells treated 
with 5.0 ug/ml BHT for 48 hr. was 24%, the specific aberrations observed 
were 1% endoreduplications and 23% polyploids. Figure 6 is a CHO cell 
treated with 5.0 ug/ml BHT, resulting in an endoreduplication with a 
triradial. Total percentage of aberrant cells observed in experimental 
cells treated with 1% DMSO for 48 hr. was 12% polyploids. In the experi¬ 
mental cells treated with 5.0 ug/ml BHT + 1% DMSO for 48 hr., there was 
a significant decrease in the total percentage (9%) of aberrant cells 
when compared to experimental cells treated with 5.0 ug/ml BHT alone. 
Figure 15-2 is a histogram comparing the total percentages of chromosomal 
aberrations and aberrant cells for CHO cells treated with 5.0 ug/ml BHT 
and 1% DMSO. 
CHO cells were also treated with 10 ug/ml BHT and 1% DMSO for 48 
hr. (Table 3A). One percent gaps was observed in control cells. The 
total percentage of chromosomal aberrations observed in the ethanol 
control was 6%; the specific aberrations observed were 2% fusion, 1% 
gaps, 1% breaks and 2% rings. CHO cells treated with 10 ug/ml BHT 
alone, showed 5% total chromosomal aberrations, the specific aberrations 
observed were 2% rings, 1% triradials and 2% dicentrics. The total 
percentage of chromosomal aberrations observed in cells treated with 1% 
DMSO was 7%; specifc aberrations included 2% gaps, 2% breaks and 3% 
rings. CHO cells treated with 10 ug/ml BHT + 1% DMSO showed 15% total 
chromosomal aberrations, which is a significant increase when compared 
to the total chromosomal aberrations observed in CHO cells treated with 
10 ug/ml BHT alone. The chromosomal aberrations observed in cells treat¬ 
ed with 10 ug/ml BHT + 1% DMSO were 3% gaps, 2% breaks, 5% triradials 
Figure 6 An endoreduplication with a tri radial (arrow) in CHO cell 
treated with 5.0 ug/ml BHT for 48 hrs. 1250X 
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Figure 15-2. Histogram comparing the total percentages of chromosomal 
aberrations and aberrant cells for CHO cells treated with 
5.0 ug/ml BHT and 1% DMSO for 48 hr. CAC, chromosomal aber¬ 
rations control, ACC, aberrant cells control; CAE, chromsomal 
aberrations ethanol; ACE, aberrant cells ethanol; CAB, chromo¬ 
somal aberrations BHT; ACB, aberrant cells BHT; CAD, chromo¬ 
somal aberrations DMSO; ACD, aberrant cells DMSO; CAF, chromo¬ 






































1% DMSO 10 ug/ml BHT 
+ 
1% DMSO 
No. of Metaphases Examined 100 100 100 100 100 
Chromosomal Aberrations (%) 
Chromosome Gaps 0 0 0 1.0 0 
Chromosome Breaks 0 0 0 0 1.0 
Chromosome Fusions 0 1.0 0 0 0 
Chromatid Gaps 0 1.0 0 1.0 1.0 
Chromatid Breaks 1.0 1.0 0 2.0 2.0 
Rings 0 2.0 2.0 3.0 5.0 
Chromatid Fusions 0 1.0 0 0 0 
Tri radiais 0 0 1.0 0 5.0 
Dicentrics 0 0 2.0 0 0 






1% DMS0 10 ug/ml BHT 
+ 
U DMS0 
Complex Interchanges 0 0 0 0 1.0 
Total Chromosomal Aberrations {%) 1.0 6.0 5.0 7.0 15.0 
Mean + SE/Metaphase — .06+.027 .05+.034 .07+.027 .15+.037 
t-test “ “ aNo significant 
difference at 
.05 level 
a»bNo significant Significant 
difference at increase at 









Level of significance 
Controls. 
Level of significance 
for increase/decrease in 
for increase/decrease in 
aberrations 
aberrations 
compared with mean 




ct-test: Level of significance for increase/decrease in aberrations compared with mean value for 
10 ug/ml BHT. 
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and 1% complex interchanges. A CHO cell treated with 10 ug/ml BHT + 
1% DMSO is shown with two triradiais (Fig. 7). 
The effects of 10 ug/ml BHT and 1% DMSO on CHO chromosomes for 48 
hr. are shown in Table 3B. Total percentage of aberrant cells observed 
in the untreated control was 5% polyploids. In the ethanol control, the 
total percentage of aberrant cells observed was 6% polyploids. CHO 
cells treated with 10 ug/ml BHT alone showed 15% total aberrant cells; 
the specific aberrations observed were 2% endoreduplications and 13% 
polyploids. Experimental cells treated with 10 ug/ml BHT alone, when 
compared to the ethanol control, showed a significant increase in aberr¬ 
ation percentage. There was a significant increase in total aberrant 
cell in experimental cells treated with 10 ug/ml BHT alone when compared 
to the ethanol control. The total percentage of aberrant cells observed 
when CHO cells were treated with 1% DMSO was 12% polyploids. The total 
percentage of aberrant cells observed in experimental cells treated with 
10 ug/ml BHT + 1% DMSO was 18% polyploids. Figure 15-3 is a histogram 
comparing the total percentages of chromosomal aberrations and aberrant 
cells for CHO cells treated with 10 ug/ml BHT and 1% DMSO. 
The summary of the effects of 1.0, 5.0 and 10 ug/ml BHT and 1% 
DMSO on CHO chromosomes for 48 hr. is shown in Table 4A. Column I 
represents the effects of 1.0 ug/ml BHT and 1% DMSO on CHO chromosomes 
for 48 hr. The total percentage of aberrations observed were 0% for un¬ 
treated control, 6% ethanol for control, 18% for BHT alone, 19% for DMSO 
alone and 10% for BHT + DMSO. Column II represents the effect of 5.0 
ug/ml BHT and 1% DMSO on CHO chromosomes for 48 hr. The total percentage 
of aberrations observed were 1% for untreated control, 5% for ethanol 
Figure 7 Two tri radiais (arrows) in a CHO cell treated with 10 ug/rnl BHT + 




Table 3B. The Effects of 10 ug/ml BHT and 1% DMSO on CHO Chromosomes for 48 hr. 
Ethanol 
Control Control 
10 ug/ml BHT 1% DMSO 10 ug/ml BHT 
+ 
1% DMSO 
No. of Metaphases Examined 100 100 100 100 100 
Aberrant Cells (%) 
Endoreduplications 0 0 2.0 0 0 
Polypi oids 5.0 6.0 13.0 12.0 18.0 cn 
Total Aberrant Cell (%) 5.0 6.0 15.0 12.0 18.0 
Mean + SE/Metaphase .06+.032 .15+.042 .12+.039 .18+.044 
t-test — aNo significant a»^Significant aNo significant ^Significant 
difference at increase at difference at increase at 




at-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
^t-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
ct-test: Level of significance for increase/decrease in aberrations compared with mean value for 
10 ug/ml BHT. 
Figure 15-3. Histogram comparing the total percentages of chromosomal 
aberrations and aberrant cells for CHO cells treated with 
10 ug/ml BHT and 1% DMSO for 48 hr. CAC, chromosomal aber¬ 
rations control; ACC, aberrant cells control; CAE, chromo¬ 
somal aberrations ethanol; ACE, aberrant cells ethanol; CAB, 
chromosomal aberrations BHT; ACB, aberrant cells BHT; CAD, 
chromosomal aberrations DMSO; CAF, chromosomal aberrations 









The effects of 10 ug/ml BHT and 1% DMSOon CHO Chromosomes for 48hrs. 
Chromosomal Aberrations 
Aberrant Cells 
CAC ACC CAE ACE CAB ACB CAD ACD CAF ACF 
47 
Table 4A. Summary of the effects of 1.0, 5.0 and 10 ug/ml BHT and 
1% DMSO on CHO Chromosomes for 48 hr. 
TOTAL PERCENTAGE OF CHROMOSOMAL ABERRATIONS 
EXPERIMENT NUMBER I II III 
Control 0 1.0 1.0 
Ethanol Control 6.0 5.0 6.0 
BHT 18.0 12.0 5.0 
DMSO 19.0 16.0 7.0 
BHT & DMSO 10.0 17.0 15.0 
I. Represents the effects of 1.0 ug/ml BHT and 1% DMSO on CHO chromosomes 
for 48 hrs. (See Table 1A for types of aberrations). 
II. Represents the effects of 5.0 ug/ml BHT and 1% DMSO on CHO chromosomes 
for 48 hrs. (See Table 2A for types of aberrations). 
III. Represents the effects of 10 ug/ml BHT and 1% DMSO on CHO chromosomes 
for 48 hrs. (See Table 3A for types of aberrations). 
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control, 12% for BHT alone, 16% for DMSO alone, and 17% for BHT + DMSO. 
Column III repressents the effect of 10 ug/ml BHT and 1% DMSO on CHO 
chromosomes for 48 hr. The total percentage of aberrations observed 
were 1% for untreated control, 6% for ethanol control, 5% for BHT alone, 
7% for DMSO alone, + 15% for BHT + DMSO. 
The summary of the effects of the 1.0, 5.0 and 10 ug/ml BHT and 
1% DMSO on CHO chromosome number for 48 hr is shown in Table 4B. The 
Column I represents the the effects of 1.0 ug/ml BHT and 1% DMSO on CHO 
chromosomes for 48 hr. The total percentage of aberrant cells observed 
were 6% for untreated control, 5% for ethanol control, 17% for BHT alone, 
12% for DMSO, and 16% for BHT + DMSO. Column II represents the effects 
of 5.0 ug/ml BHT and 1% DMSO on CHO chromosomes for 48 hr. The total 
percentage of aberrant cells observed were 3% for untreated control, 3% 
for ethanol, 24% for BHT alone, 12% for DMSO, and 9% for BHT + DMSO. 
Column III represents the effect of 10 ug/ml BHT and 1% DMSO on CHO 
chromosomes for 48 hr. The total percentage of aberrant cells observed 
were 5% for untreated control, 6% for ethanol control, 15% for BHT 
alone, 12% for DMSO, + 18% for BHT and DMSO. 
BHT and TEMPONE Studies 
The effects of a 48 hr. treatment of CHO cells with 1.0 ug/ml BHT 
and 1.0 ug/ml TEMPONE on are shown in Table 5A. The total percentage of 
chromosomal aberrations observed in experimental cells treated with 1.0 
ug/ml BHT alone was 10% as compared to 1% in the untreated control and 
6% in the ethanol control. Experimentally induced aberrations observed 
were 3% rings, 1% tri radiais and 6% dicentrics. The total percentage of 
chromosomal aberrations observed in experimental cells treated with 1.0 
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TABLE 4B. Summary of the Effects of 1.0, 5.0 and 10 ug/ml BHT and 1% DMSO 
on CHO Chromosomes for 48 hr. 
TOTAL PERCENTAGE OF ABERRANT CELLS 
EXPERIMENT NUMBER I II III 
Control 6.0 3.0 5.0 
Ethanol Control 5.0 3.0 6.0 
BHT 17.0 24.0 15.0 
DMSO 12.0 12.0 12.0 
BHT & DMSO 16.0 9.0 18.0 
I. Represents the effects of 1.0 ug/ml BHT and 1% DMSO on CHO Chromosomes 
for 48 hrs. (See Table IB for types of aberrations). 
II. Represents the effects of 5.0 ug/ml BHT and 1% DMSO on CHO Chromosomes 
for 48 hrs. (See Table 2B for types of aberrations). 
III. Represents the effects of 10 ug/ml BHT and 1% DMSO on CHO Chromosomes 
for 48 hrs. (See Table 3B for types of aberrations). 
Table 5A. The Effects of 1.0 ug/ml BHT and 1.0 ug/ml TEMP0NE on CH0 Chromosomes for 48 hr. 
Ethanol 1.0 ug/ml 1.0 ug/ml 1.0 ug/ml BHT 
Control Control BHT TEMP0NE + 
1.0 ug/ml TEMP0NE 
No. of Metaphases Examined 100 100 100 100 100 
Chromosomal Aberrations (%) 
Chromosome Breaks 0 0 0 2.0 0 
Chromosome Gaps 0 1.0 0 0 1.0 
Chromatid Breaks 0 2.0 0 6.0 1.0 
Chromatid Fusions 0 0 0 2.0 0 
Ri ngs 0 0 3.0 2.0 2.0 
Tri radiais 0 0 1.0 1.0 0 
Dicentrics 0 2.0 6.0 6.0 8.0 
Pulverized Chromosomes 0 0 0 1.0 0 
Complex Interchanges 0 0 0 1.0 0 












Fragments 1.0 1.0 0 2.0 1.0 
Total Chromosomal Aberrations (%) 1.0 6.0 10.0 23.0 13.0 
Mean + SE/Metaphase — .06+.025 .10+.031 .23+.043 .13+.035 





















Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
Level of significance for increase/decrease in aberrations compared with mean value for 
1.0 ug/ml BHT. 
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ug/ml TEMPONE for 48 hr. was 23%; specific aberrations include 8% breaks, 
2% fusions, 2% rings, 6% dicentrics, 1% pulverized chromosomes, 1% com¬ 
plex interchanges and 2% fragments. In the experimental cells treated 
with 1.0 ug/ml BHT + 1.0 ug/ml TEMPONE for 48 hr. there was no signifi¬ 
cant difference in the total percentage of chromosomal aberrations as 
compared to experimental cells treated with 1.0 ug/ml BHT alone for 48 
hr. The following aberration percentages were observed: 1% gaps, 1% 
breaks, 2% rings, 8% dicentrics and 1% fragments. 
Table 5B shows the effects of 1.0 ug/ml BHT and 1.0 ug/ml TEMPONE 
on CHO chromosomes for 48 hr. The total percentage of aberrant cells 
observed in the untreated control was 3% polyploids. The total percent¬ 
age of aberrant cells observed in the ethanol control was 5% polyploids. 
CHO cells treated with 1.0 ug/ml BHT alone showed 16% total aberrant 
cells (1% endoreduplications and 15% polyploids). There was a signifi¬ 
cant increase in the total percentage of aberrant cells in experimental 
cells treated with 1.0 ug/ml BHT alone. CHO cells treated with 1.0 
ug/ml TEMPONE alone showed a total of 13% aberrant cells (2% endoredupli- 
cations and 11% polyploids). Figure 8 is a polyploidy and a dicentric in 
a CHO cell treated with 1.0 ug/ml TEMPONE. In the experimental group 
with simultaneous treatment of 1.0 ug/ml BHT + 1.0 ug/ml TEMPONE, there 
was no significant difference in total percentages of aberrant cells 
when compared to experimental cells treated with 1.0 ug/ml BHT alone 
for 48 hr. A polyploidy with a chromatid break and a dicentric (Fig. 9) 
was observed in a CHO cell treated with 1.0 ug/ml BHT + 1.0 ug/ml TEMPONE. 
A histogram comparing the total percentage of chromosomal aberrations 
and aberrant cells for CHO cells treated with 1. 0 ug/ml TEMPONE is 





1.0 ug/ml 1.0 ug/ml/BHT 
TEMPONE + 
1.0 ug/ml/TEMPONE 
No. of Metaphases Examined 100 100 100 100 100 
Aberrant Cells (%) 
Endoreduplications 0 1.0 1.0 2.0 1.0 
Polypi oi ds 3.0 4.0 15.0 11.0 14.0 
Total Aberrant Cell (%) 3.0 5.0 16.0 13.0 15.0 
Mean + SE/Metaphase — .05+.027 .16+.040 .13+.037 • 15+.039 
t-test — aNo significant Significant Significant Significant 
difference at increase at increase at increase at 










at-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
^t-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
ct-test: Level of significance for increase/decrease in aberrations compared with mean value for 
1.0 ug/ml. 
Figure 8. A polyploidy and a dicentric (arrow) in a CHO cell treated with 
1.0 ug/ml TEMPONE for 48 hr. 1250X 
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Figure 9. A polyploidy with a chromatid break (arrow) and a dicentric 
(arrow) in a CHO cell treated with 1.0 ug/ml BHT + 1.0 ug/ml 
TEMPONE for 48 hr. 1250X 
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shown in Fig. 15-4. 
Table 6A contains data for CHO cells treated with 5.0 ug/ml 
BHT and 5.0 ug/ml TEMPONE for 48 hr. A total of 1% gaps was observed 
in untreated control cells. The total percentage of chromosomal aberr¬ 
ations observed in the ethanol control was 3%; specific aberrations 
include 1% gaps, 1% dicentrics and 1% complex interchanges. In the 
experimental cells treated with 5.0 ug/ml BHT alone, there was a signi¬ 
ficant increase in total percentage of chromosomal aberrations when com¬ 
pared to the ethanol control. The total percentage of chromosomal aber¬ 
rations observed in experimental cells treated with 5.0 ug/ml TEMPONE 
for 48 hr. was 21%; specific aberrations include 4% gaps, 3% breaks, 5% 
rings, 2% triradials, 5% dicentrics and 2% fragments. Figure 10 is a 
chromatid break in a CHO cell treated with 5.0 ug/ml TEMPONE. CHO cells 
treated with 5.0 ug/ml BHT and 5.0 ug/ml TEMPONE showed a total percent¬ 
age of 16% chromosomal aberrations; the types of aberrations observed 
were 4% gaps, 5% breaks, 3% triradials and 4% dicentrics. Figure 11 is 
a polyploidy, chromatid break and a dicentric in a CHO cell treated 
with 5.0 ug/ml BHT + 5.0 ug/ml TEMPONE. 
The effects of 5.0 ug/ml BHT and 5.0 ug/ml TEMPONE on CHO chromo¬ 
some number for 48 hr. are shown in Table 6B. The total percentage of 
aberrant cells observed in expérimentais treated with 5.0 ug/ml BHT 
alone was 21% polyploids as compared to 4% polyploids in the untreated 
cells and 6% polyploids in the ethanol control. CHO cells treated with 
5.0 ug/ml TEMPONE for 48 hr. showed 17% total percentage of aberrant 
cells (polyploids). Cells treated with 5.0 ug/ml BHT + 5.0 ug/ml TEMPONE 
contained 1% endoreduplications and 18% polyploids. Figure 15-5 is a 
Figure 15-4. Histogram comparing the total percentages of chromosomal 
aberrations and aberrant cells for CHO cells treated with 
1.0 ug/ml BHT and 1.0 ug/ml TEMPONE for 48 hr. CAC, chromo¬ 
somal aberrations control; ACC, aberrant cells control; CAE, 
chromosomal aberrations ethanol; ACE, aberrant cells ethanol; 
CAB, chromosomal aberrant cells BHT; CAT, chromosomal aber¬ 
rations TEMPONE; ACT, aberrant cells TEMPONE; CAS, chromosomal 
aberration BHT + TEMPONE; ACS, aberrant cells BHT + TEMPONE. 
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5.0 ug/ml BHT 
+ 
5.0 ug/ml TEMPONE 
No. of Metaphases Examined 100 100 100 100 100 
Chromosomal Aberrations (%) 
Chromosome Gaps 0 0 0 0 1.0 
Chromosome Breaks 0 0 0 1.0 2.0 
Chromsomes Fusions 0 0 1.0 0 0 
Chromatid Gaps 1.0 1.0 3.0 4.0 3.0 
Chromatid Breaks 0 0 0 2.0 3.0 
Chromatid Fusions 0 0 1.0 0 0 
Ri ngs 0 0 2.0 5.0 0 
Tri radiais 0 0 0 2.0 3.0 
Dicentrics 0 1.0 5.0 5.0 4.0 








5.0 ug/ml BHT 
+ 
5.0 ug/ml TEMP0NE 
Pulverized Chromosomes 0 0 1.0 0 0 
Complex Interchanges 0 1.0 0 0 0 
Fragments 0 0 0 2.0 0 
Total Chromosomal Aberrations (%) 1.0 3.0 13.0 21.0 16.0 
Mean + SE/Metaphase — .03+.019 .13+.035 .21+.042 .16+.038 
t-test — aNo significant a»bSignificant aSignificant a » bSignificant 
difference at increase at increase at increase at 




at-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
bt-test: Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
ct-test: Level of significance for increase/decrease in aberrations compared with mean value for 
5.0 ug/ml BHT. 
Figure 10. A chomatid break (arrow) in a CHO cell treated with 5.0 ug/ml 
TEMPONE. 1250X 
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Figure 11. A polyploidy, a dicentric (arrow) and a chromatid break (arrow) 
in a CHO cell treated with 5.0 ug/ml BHT + 5.0 ug/ml TEMPONE 











5.0 ug/ml BHT 
+ 
5.0 ug/ml BHT 
No. of Metaphases Examined 100 100 100 100 100 
Aberrant Cell (%) 
Endoreduplications 0 0 0 0 1.0 
Polypi oi ds 4.0 6.0 21.0 17.0 18.0 
Total Aberrant Cell (%) 4.0 6.0 21.0 17.0 19.0 
Mean + SE/Metaphase — .06+.030 .21+.045 .17+.042 .19+.044 















at-test: Level of significance for increase/decrease in aberrations compared with mean value for Controls, 
^t-test: Level of significance for increase/decrease in aberrations compared with mean value for Ethanol 
Controls. 
Level of significance for increase/decrease in aberrations compared with mean value for 
5.0 ug/ml BHT. 
ct-test: 
Figure 15-5. Histogram comparing the total percentages of chromosomal 
aberrations and aberrant cells for CHO cells treated with 
5.0 ug/ml BHT and 5.0 ug/ml TEMPONE for 48 hr. CAC, chromo¬ 
somal aberrations control; ACC, aberrant cells control; CAE, 
chromosomal aberrations ethanol; ACE, aberrant cells ethanol; 
CAB, chromosomal aberrations BHT; CAT, chromosomal aberrations 
TEMPONE; CAS, chromosomal aberrations BHT + TEMPONE; ACS, 
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histogram comparing the total percentage of chromosomal aberrations and 
aberrant for CHO cells treated with 5.0 ug/ml BHT and 5.0 ug/ml TEMPONE. 
The effects of 10 ug/ml BHT and 10 ug/ml TEMPONE on CHO chromo¬ 
somes for 48 hr. are shown in Table 7A. Total percentage of chromo¬ 
somal aberrations observed in experimental cells treated with 10 ug/ml 
BHT were 8% as compared to 2% in the untreated control and 4% in the 
ethanol control. Chromosomal aberrations observed in the BHT experi¬ 
mental groups were 1% gaps, 1% breaks, 1% dicentrics and 5% fragments. 
Figure 12 is a CHO cell treated with 10 ug/ml BHT, resulting in a ring. 
The total percentage of chromosomal aberration observed in experimental 
cells treated with 10 ug/ml TEMPONE for 48 hr. was 4%; specific aber¬ 
rations include 1% breaks, 1% fusions and 2% rings. In the experimental 
cells treated with 10 ug/ml BHT + 10 ug/ml TEMPONE for 48 hr., there 
was no significant difference in the total percentage of chromosomal 
aberrations when compared to experimental cells treated with 10 ug/ml 
BHT alone. The following aberrations were observed: 3% gaps, 2% breaks 
and 1% rings. 
Table 7B shows the effects of 10 ug/ml BHT and 10 ug/ml TEMPONE 
on CHO chromosomes for 48 hr. The percentage of aberrant cells observed 
in the untreated control was 3% polyploids; 8% polyploids were observed 
in the ethanol control. Experimental cells treated with 10 ug/ml BHT 
for 48 hr. contained 12% polyploids; this percentage of aberrant cells 
did not represent a significant difference as compared to the ethanol 
control. The percentage of aberrant cells observed in experimental 
cells treated with 10 ug/ml TEMPONE alone was 11% polyploids. Figure 13 
is a polyploidy and two rings in a CHO cell treated with 10 ug/ml TEMPONE. 








10 ug/ml BHT 
+ 
10 ug/ml TEMPONE 
No. of Metaphases Examined 100 100 100 100 100 
Chromosomal Aberrations (%) 
Chromosome Gaps 0 0 1.0 0 0 
Chromosome Breaks 0 0 1.0 0 1.0 
Chromatid Breaks 0 1.0 0 1.0 1.0 
Chromatid Gaps 2.0 1.0 0 0 3.0 
Chromatid Fusions 0 0 0 1.0 0 
Rings 0 0 0 2.0 1.0 
T ri radi al s 0 1.0 0 0 0 
Dicentrics 0 0 1.0 0 0 







10 ug/ml BHT 
+ 
10 ug/ml TEMP0NE 
Fragments 0 1.0 5.0 0 0 
Total Chromosomal Aberrations % 2.0 4.0 8.0 4.0 6.0 
Mean + SE/Metaphase .04+.024 .08+.030 .04+.024 .06+.027 


















Level of significance for increase/decrease in aberrations compared with mean 
Controls. 
Level of significance for increase/decrease in aberrations compared with mean 
Ethanol Controls. 
Level of significance for increase/decrease in aberrations compared with mean 




A ring (arrow) in a CHO cell treated with 10 ug/rnl BHT for 48 hr. 
1250X 
67 







10 ug/ml BHT 
+ 
10 ug/ml TEMPONE 
No. of Metaphases Examined 100 100 100 100 100 
Aberrant Cells (%) 
Polypioids 3.0 8.0 12.0 11.0 14.0 
Total Aberrant Cell (%) 3.0 8.0 12.0 11.0 14.0 
Mean + SE/Metaphases — .08+032 .12+.-36 .11+.035 .14+.038 





















Level of significance for increase/decrease in aberrations compared with mean value for 
Controls. 
Level of significance for increase/decrease in aberrations compared with mean value for 
Ethanol Controls. 
Level of significance for increase/decrease in aberrations compared with mean value for 
10 ug/ml BHT. 
Figure 13. A polyploidy and two rings (arrows) in a CHO cell treated with 
10 ug/ml TEMPONE for 48 hr. 1250X 
69 
A polyploidy and a chromatid break (arrow) in a CHO cell treated 
with 10 ug/ml BHT + 10 ug/ml TEMPONE for 48 hr. 1250X 
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The experimental cells exposed to 10 ug/ml BHT + 10 ug/ml TEMPONE for 48 
hr., showed no significant difference in total aberrant cell percentages 
when compared to experimental cells treated with 10 ug/ml BHT alone. 
Figure 14 is a polyploidy and a chromatid break in a CHO cell treated with 
10 ug/ml BHT + 10 ug/ml TEMPONE. A histogram comparing the total per¬ 
centages of chromosomal aberrations and aberrant cells for CHO cells 
treated with 10 ug/ml BHT and 10 ug/ml TEMPONE is shown in Fig. 15-6. 
The summary of the effect of 1.0, 5.0 and 10 ug/ml BHT and 1.0, 
5.0 and 10 ug/ml TEMPONE on CHO chromosomes for 48h hr. is shown in 
Table 8A. Column I represents the effects of 1.0 ug/ml BHT and 1.0 
ug/ml TEMPONE on CHO chromosomes for 48 hr. The total percentage of 
aberrations observed were 1% for untreated control, 6% for ethanol con¬ 
trol, 10% for BHT alone, 23% for TEMPONE, and 13% for BHT + TEMPONE. 
Column II represents the effects of 5.0 ug/ml BHT and 5.0 ug/ml TEMPONE 
on CHO chromosomes for 48 hr. The total percentage of aberrations obser¬ 
ved were 1% for untreated control, 3% for ethanol control, 13% for BHT 
alone, 21% for TEMPONE, and 16% for BHT + TEMPONE. Column III represents 
the effects of 10 ug/ml BHT and 10 ug/ml TEMPONE on CHO chromosomes for 
48 hr. The total percentage of aberrations observed were 2% for untreat¬ 
ed control, 4% for ethanol control, 8% for BHT, 4% for TEMPONE, and 11% 
BHT + TEMPONE. 
The summary of the effects of 1.0, 5.0 and 10 ug/ml BHT and 1.0, 
5.0 and 10 ug/ml TEMPONE on CHO chromosome number for 48 hrs is shown 
in Table 8B. Column I represents the effects of 1.0 ug/ml BHT and 1.0 
ug/ml TEMPONE on CHO chromosomes for 48 hr. The total percentage of 
aberrant cells observed were 3% for untreated control, 5.0 for ethanol 
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Figure 15-6. Histogram comparing the total percentages of chromosomal 
aberrations and aberrant cells for CHO cells treated with 
10 ug/ml BHT and 10 ug/ml TEMPONE for 48 hr. CAC, chromo¬ 
somal aberrations control; ACC, aberrant cells control; CAE, 
chromosomal aberrations ethanol; CAB, chromosomal aberrations 
BHT; ACB, aberrant cells BHT; CAT, chromosomal aberrations 
TEMPONE; ACT, aberrant cells TEMPONE; CAS, chromosomal aber¬ 
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15-6 
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Table 8A. Summary of the Effects of 1.0, 5.0 and 10 ug/ml BHT and 
1.0, 5.0 and 10 ug/ml TEMPONE on CHO Chromosomes 
for 48 hr. 
TOTAL PERCENTAGE OF CHROMOSOMAL ABERRATIONS 
EXPERIMENT NUMBER I II III 
Control 1.0 1.0 2.0 
Ethanol 6.0 3.0 4.0 
BHT 10.0 13.0 8.0 
TEMPONE 23.0 21.0 4.0 
BHT & TEMPONE 13.0 16.0 6.0 
I. Represents the effects of 1.0 ug/ml BHT and 1.0 ug/ml TEMPONE on CHO 
chromosomes for 48 hrs. (See Table 5A for types of aberrations). 
II. Represents the effects of 5.0 ug/ml BHT and 5.0 ug/ml TEMPONE TEMPONE 
on CHO chromosomes for 48 hrs. (See Table 6A for types of aberrations). 
III. Represents the effects of 10 ug/ml BHT and 10 ug/ml TEMPONE on CHO 
chromosomes for 48 hrs. (See Table 7A for types of aberrations). 
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Table 8B. Summary of the effects of 1.0, 5.0 and 10 ug/ml BHT and 
1.0, 5.0 and 10 ug/ml TEMPONE on CHO Chromosomes 
48 hr. 
TOTAL PERCENTAGE OF ABERRANT CELLS 
EXPERIMENT NUMBER I II III 
Control 3.0 4.0 3.0 
Ethanol Control 5.0 6.0 8.0 
BHT 16.0 21.0 12.0 
TEMPONE 13.0 17.0 11.0 
BHT & TEMPONE 15.0 19.0 14.0 
I. Represents the effects of 1.0 ug/ml BHT and 1.0 ug/ml TEMPONE on CHO 
chromosomes for 48 hrs. (See Table 5B for types of aberrations). 
II. Represents the effects of 5.0 ug/ml BHT and 5.0 ug/ml TEMPONE on CHO 
chromosomes for 48 hrs. (See Table 6B for types of aberrations). 
III. Represents the effects of 10 ug/ml BHT and 10 ug/ml TEMPONE on CHO 
chromosomes for 48 hrs. (See Table 7B for types of aberrations). 
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control, 16% for BHT alone, 13% for TEMPONE, and 15% BHT + TEMPONE. The 
total percentage of aberrant cells are shown under Column II for 5.0 ug/ml 
BHT and 5.0 ug/ml TEMPONE for 48 hr on CHO chromosome. The total per¬ 
centage of aberrant cells observed were 4% for untreated control, 6% for 
ethanol control, 21% for BHT alone, 17% for TEMPONE 19 and % for BHT + 
TEMPONE. Column III represents the effects of 10 ug/ml BHT and 10 ug/ml 
TEMPONE on CHO chromosomes for 48 hr. The total percentage of aberrant 
cells observed were 3% for untreated control, 8% for ethanol control, 
12% for BHT alone, 11% for TEMPONE, and 14% for BHT + TEMPONE. 
CHAPTER V 
DISCUSSION 
Initially, these investigations sought to elucidate the possible 
synergistic action of BHT with DMSO or TEMPONE by analyzing the per¬ 
centage of aberrations of BHT alone and DMSO or TEMPONE alone, and 
comparing the percentages obtained when the chemicals were combined 
in various combinations (i.e. BHT + DMSO or BHT + TEMPONE). 
It was observed that in the BHT and DMSO studies, the highest per¬ 
centage of chromosomal aberrations induced by BHT was in CHO cells treated 
with 1.0 ug/ml BHT alone. There was a significant decrease in the per¬ 
centage of chromosomal aberrations in CHO cells treated with 10 ug/ml BHT 
alone. It is possible that 10 ug/ml BHT may be slightly toxic to the cells 
and reduces the number of chromosomal aberrations; this may be possible 
since 20 ug/ml BHT caused cell death in CHO expérimentais. Experimental 
results for the effects of 1.0 ug/ml BHT and 1% DMSO indicated that there 
was not a significant difference between the total percentages of chromo¬ 
somal aberrations (18%) and aberrant cells (17%) when CHO cells were 
treated with 1.0 ug/ml BHT alone. There was a significant reduction in 
chromosomal aberrations when CHO cells were treated with 1.0 ug/ml BHT + 
DMSO. These results suggest that BHT may be acting as an antioxidant in 
its interaction with DMSO; however, it is also possible that the effects 
of toxicity may play a role in the reduction of chromosomal aberrations, 
since the number of viable replicating cells were reduced. 
It was observed in the BHT and DMSO studies that the total percent- 
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age of aberrant cells was twice the total percentage of chromosomal 
aberrations when expérimentais were treated with 5.0 ug/ml BHT alone. 
It was also noted that there was a significant reduction in aberrant 
cells when expérimentais where exposed to 5.0 ug/ml BHT + 1% DMSO. 
Again, BHT may be acting as an antioxidant at this particular concen¬ 
tration with 1% DMSO. 
In each of the experiments for the BHT and DMSO studies 1% DMSO was 
used. The results observed suggest that DMSO tends to increase the per¬ 
centage of chromosomal aberrations rather than the percentage of aberrant 
cells. It was also observed that in one of the studies the effects of 
10 ug/ml BHT and 1% DMSO on CHO chromosomes, the percentage of aberrant 
cells was higher than the percentage of chromosomal aberrations when 
CHO cells were treated with IX DMSO alone. The exact cause for this 
change is unknown; however, the passage number of the cells for this 
particular experiment was slightly higher than the other experiments, 
and this may have affected the experimental results. 
The studies for BHT and DMSO also suggest the presence of a dose 
response to BHT. The total percentage of aberrant cells increased when 
the concentration of BHT was increased from 1.0 ug/ml to 5.0 ug/ml; 
however, the percentage of aberrant cells was reduced when the concent¬ 
ration was increased to 10 ug/ml BHT, which may be related to the toxi¬ 
city of BHT. 
The data for the BHT and TEMP0NE studies indicated that there was a 
higher percentage of aberrant cells than chromosomal aberrations for CHO 
cells treated with 1.0 ug/ml BHT alone or 1.0 ug/ml TEMP0NE alone. It 
was also noted that there was no significant difference in chromosomal 
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aberrations or aberrant cells for expérimentais treated with 1.0 ug/ml 
BHT + 1.0 ug/ml TEMPONE. 
In these studies BHT, DMSO and TEMPONE at specific concentrations, 
significantly increased the percentage of aberrant cells (i.e. endore- 
duplications and polyploidy). The occurrence of aberrant cell in CHO 
experiments treated with BHT may be correlated to previous studies which 
have shown that BHT increases DNA content in pulmonary cells in vivo 
(Sahab and Witschi, 1975). The investigators observed that the total 
lung weight in Swiss-Webster mice increased significantly after BHT 
treatment, and decreased slightly toward normal; however, even after 9 
days following BHT injections, treated animals had a significantly 
increased lung weight compared with controls. Omaye (1977) provided 
further evidence when he observed that BHT (62.5, 215 and 500 mg/kg) 
significantly increased the lung weight in a dose-dependent manner. 
The increase in lung weight was accompanied by increases in lung DNA and 
nonprotein sulfhydrl levels and enzyme activities of glutathione (GSH), 
peroxidase, GSH reductase glucose-6-phosphate dehydrogenase, and super¬ 
oxide dismutase. Witschi and Lock (1978) reported a 1.7 fold increased 
in the total amount of DNA over control values. 
The studies for BHT and TEMPONE also suggest the presence of a dose 
response to BHT, which was anticipated since this phenomenon occurred 
in the BHT and DMSO studies. TEMPONE demonstrated a dose response as 
the concentration was increased from 1.0 ug/ml to 5.0 ug/ml. Again, the 
reduction in the percentage of aberrant cells when experimental treated 
with 10 ug/ml TEMPONE may be indicative of the toxic effects of TEMPONE. 
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The observations reported here support previous studies that BHT 
causes an increase in chromosomal aberrations in mammalian cells in 
vitro (Miller, Personal Communication). It supports previous studies 
of Kapp and Eventoff (1980) and Patterson and Smalls (1981) that DMSO 
causes chromosomal aberrations in mammalian cells. It also confirms 
observations that TEMPONE causes chromosomal aberrations in cell cultures 
(Dawkins, et al., 1980). 
In conclusion, BHT does not interact synergistically or additively 
with DMSO or TEMPONE; however, the cytogenetic effects of BHT are dose 
dependent and may act as a weak mutagenic agent in CHO cells in vitro. 
The studies presented here, cannot distinguish between the mutagenic or 
toxic effects of BHT as related to the increase in the percentage of 
chromosomal aberrations observed when cells were treated with 10 ug/ml 
BHT + 1% DMSO. BHT has been reported to act as an antioxidant by reduc¬ 
ing chromosomal breaks in blood leukocyte cultures treated with sodium 
cyclamate and 7,12-dimethylbenz(alpha)anthracine (Shamberger et al., 
1973). Thus, the antioxidant properties of BHT in these studies were 
postulated to effect the observed decrease in chromosomal aberrations 
and aberrant cells; however, as previously stated the toxic effects of 
BHT may have caused the reduction in the total aberration percentages. 
Moreover, the incidence of aberrant cells (i.e. polyploidy and endore- 
duplications) suggests an alteration in the cell cycle which may be 
related to the mutagenic effects of BHT, but cytogenetic studies alone 
cannot elucidate this phenomenon. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
The objective of this work was to test the possible synergistic 
action of the antioxidant Butylated hydroxytoluene (BHT) with 
Dimethyl sulfoxide (DMSO) and 2,2,6,6-tertramethyl-4-oxo-piperidin- 
1-oxyl (TEMPONE) on CHO cells. 
Cytogenetic analysis indicated that BHT caused an increase in 
chromosomal aberrations and aberrant cells in CHO cells treated 
for 48 hrs., as compared to controls. 
Cytogenetic analysis also reveals that a concentration of 10 ug/ml 
BHT may be slightly toxic to CHO cells. 
Cytogenetic analysis indicated that 1% DMSO caused an increase in 
chromosomal aberrations and aberrant cells in CHO cells treated 
for 48 hrs., as compared to untreated controls. 
There is a significant decrease at the .05 level in chromosomal 
aberrations when CHO cells were treated with 1.0 ug/ml BHT and 
1% DMSO. 
There is a significant decrease at the .05 level in aberrant cells 
when CHO cells were treated with 5.0 ug/ml BHT and 1% DMSO. 
Cytogenetic analysis also reveals that TEMPONE caused an increase 
in chromosomal aberrations and aberrant cells in CHO cell cultures 
treated for 48 hrs., as compared to untreated controls. 
TEMPONE (10 ug/ml) may be slightly toxic to CHO cells. 
There is no significant difference at the .05 level in chromosomal 
aberrations or aberrant cells when CHO cells were treated with 1.0, 
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5.0 or 10 ug/ml BHT and 1.0, 5.0 or 10 ug/ml TEMPONE. 
10. Further studies are planned to evaluate the possible mechanism(s) 
for the interaction of BHT with DMS0 and TEMPONE. 
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